Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma

Clinical trial NCT06029309 · RECRUITING

Trial details

NCT number: NCT06029309
Sponsor: Alvaro Alencar, MD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2024-05-03
Primary completion: 2028-05-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.